Turning point: A new global COVID‐19 wave or a signal of the beginning of the end of the global COVID‐19 pandemic?
Open Access
- 29 March 2022
- journal article
- review article
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 10 (4) , e606
Abstract
A new variant named Omicron (B.1.1.529), first identified in South Africa, has become of considerable interest to the World Health Organization. This variant differs from the other known major variants, as it carries a large number of unusual mutations, particularly in the spinous process protein and receptor binding domains. Some specific mutation sites make it vaccine resistant, highly infectious, and highly pathogenic. The world fears that the Omicron variant could be even more harmful than the previous major variant, given that it has emerged amid fierce competition to trigger a new global pandemic peak as infections in South Africa rise. However, some epidemiological evidence has emerged that the Omicron variant may produce milder patient symptoms. We speculate if the virulence of the Omicron variant will diminish as transmissibility increases, thereby signaling the beginning of the end for the global COVID‐19 pandemic. Based on this view, we make recommendations for COVID‐19 mitigation in the present and future. However, it will take a few weeks to determine the true threat posed by the Omicron variant and we need to be fully prepared for future outbreaks, regardless of their severity.Keywords
This publication has 51 references indexed in Scilit:
- Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021Emerging Infectious Diseases, 2022
- Detection of highly muted coronavirus variant Omicron (B.1.1.529) is triggering the alarm for South Asian countries: Associated risk factors and preventive actionsJournal of Medical Virology, 2021
- Urgent call for mass immunization against coronavirus in BangladeshScience Progress, 2021
- The “Delta Plus” COVID-19 variant has evolved to become the next potential variant of concern: mutation history and measures of preventionJournal of Basic and Clinical Physiology and Pharmacology, 2021
- To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccinationExpert Review of Vaccines, 2021
- Bangladesh reported delta variant of coronavirus among its citizen: Actionable items to tackle the potential massive third waveInfection Prevention in Practice, 2021
- The massive attack of COVID‐19 in India is a big concern for Bangladesh: The key focus should be given on the interconnection between the countriesThe International Journal of Health Planning and Management, 2021
- Vaccin BioNTech-Pfizer mode d’emploiRevue Francophone des Laboratoires, 2021
- Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529)Zoonoses, 2021
- Fair Allocation of Scarce Medical Resources in the Time of Covid-19New England Journal of Medicine, 2020